Sally Jarvela

Summary

Affiliation: Tampere University Hospital
Country: Finland

Publications

  1. Jarvela S, Rantala I, Rodriguez A, Kallio H, Parkkila S, Kinnula V, et al. Specific expression profile and prognostic significance of peroxiredoxins in grade II-IV astrocytic brain tumors. BMC Cancer. 2010;10:104 pubmed publisher
    ..0052 and p = 0.0002). The expression of Prx I and Prx II correlates with astrocytic tumor features, such as grade and patient age and proliferation activity (Prx I), and accordingly with patient survival. ..
  2. Carson Walter E, Winans B, Whiteman M, Liu Y, Jarvela S, Haapasalo H, et al. Characterization of TEM1/endosialin in human and murine brain tumors. BMC Cancer. 2009;9:417 pubmed publisher
    ..The cellular localization of TEM1/endosialin and its expression profile in primary and metastatic brain tumors support efforts to therapeutically target this protein, potentially via antibody mediated drug delivery strategies. ..
  3. Jarvela S, Parkkila S, Bragge H, Kähkönen M, Parkkila A, Soini Y, et al. Carbonic anhydrase IX in oligodendroglial brain tumors. BMC Cancer. 2008;8:1 pubmed publisher
    ..It may have a role in the biology of oligodendrogliomas, and most interestingly, as it is mainly expressed in tumor tissue, CA IX could serve as a target molecule for anticancer treatments. ..
  4. request reprint
    Jarvela S, Jarvela T, Aho H, Kiviranta I. Arthroscopic subacromial decompression: outcome comparison between outpatient and hospitalized patients with 2- to 5-year follow-up. Scand J Surg. 2010;99:50-4 pubmed
    ..The results were significantly better at follow-up than preoperatively in both groups. Key words: Shoulder pain; subacromial impingement; arthroscopic subacromial decompression; outpatient unit; hospitalized patient; clinical result. ..

Detail Information

Publications4

  1. Jarvela S, Rantala I, Rodriguez A, Kallio H, Parkkila S, Kinnula V, et al. Specific expression profile and prognostic significance of peroxiredoxins in grade II-IV astrocytic brain tumors. BMC Cancer. 2010;10:104 pubmed publisher
    ..0052 and p = 0.0002). The expression of Prx I and Prx II correlates with astrocytic tumor features, such as grade and patient age and proliferation activity (Prx I), and accordingly with patient survival. ..
  2. Carson Walter E, Winans B, Whiteman M, Liu Y, Jarvela S, Haapasalo H, et al. Characterization of TEM1/endosialin in human and murine brain tumors. BMC Cancer. 2009;9:417 pubmed publisher
    ..The cellular localization of TEM1/endosialin and its expression profile in primary and metastatic brain tumors support efforts to therapeutically target this protein, potentially via antibody mediated drug delivery strategies. ..
  3. Jarvela S, Parkkila S, Bragge H, Kähkönen M, Parkkila A, Soini Y, et al. Carbonic anhydrase IX in oligodendroglial brain tumors. BMC Cancer. 2008;8:1 pubmed publisher
    ..It may have a role in the biology of oligodendrogliomas, and most interestingly, as it is mainly expressed in tumor tissue, CA IX could serve as a target molecule for anticancer treatments. ..
  4. request reprint
    Jarvela S, Jarvela T, Aho H, Kiviranta I. Arthroscopic subacromial decompression: outcome comparison between outpatient and hospitalized patients with 2- to 5-year follow-up. Scand J Surg. 2010;99:50-4 pubmed
    ..The results were significantly better at follow-up than preoperatively in both groups. Key words: Shoulder pain; subacromial impingement; arthroscopic subacromial decompression; outpatient unit; hospitalized patient; clinical result. ..